IP Daily

HOME > 분쟁정보 > IP 분쟁동향 > IP Daily
ipdailyplus 아이콘

[IP Daily Plus+]는 개별 신청을 통해 소장원문, 계쟁특허,분쟁이력 등의 추가정보를 제공해드리는 서비스입니다.

IP Daily Plus
[의약품] H. Lundbeck A/S/ Takeda Pharmaceuticals America, Inc./ TAKEDA PHARMACEUTICALS USA, Inc./ Takeda Pharmaceutical Company Ltd/ Takeda Pharmaceuticals International AG 대 Torrent Pharmaceuticals Limited/ Torrent Pharma, Inc. 간의 특허 분쟁
H. Lundbeck A/S/ Takeda Pharmaceuticals America, Inc./ TAKEDA PHARMACEUTICALS USA, Inc./ Takeda Pharmaceutical Company Ltd/ Takeda Pharmaceuticals International AG v. Torrent Pharmaceuticals Limited/ Torrent Pharma, Inc.
발생일자 2018.05.03
사건번호 1:18-cv-00672
법원국가 UNITED STATES OF AMERICA
관할법원명 D.C.Delaware(지방법원)
침해권리 특허
원고명 H. Lundbeck A/S/ Takeda Pharmaceuticals America, Inc./ TAKEDA PHARMACEUTICALS USA, Inc./ Takeda Pharmaceutical Company Ltd/ Takeda Pharmaceuticals International AG ( H. Lundbeck A/S/ Takeda Pharmaceuticals America, Inc./ TAKEDA PHARMACEUTICALS USA, Inc./ Takeda Pharmaceutical Company Ltd/ Takeda Pharmaceuticals International AG / 덴마크 / 외국기업 )
피고명 Torrent Pharmaceuticals Limited/ Torrent Pharma, Inc. ( Torrent Pharmaceuticals Limited/ Torrent Pharma, Inc. / 인도 / 외국기업 )
소송유형 침해금지
분쟁내용 [H. Lundbeck A/S/ Takeda Pharmaceuticals America, Inc. et al v. Torrent Pharmaceuticals Limited et al] 사건번호 1:18-cv-00672에 따르면 원고 H. Lundbeck A/S/ Takeda Pharmaceuticals America, Inc./ TAKEDA PHARMACEUTICALS USA, Inc./ Takeda Pharmaceutical Company Ltd/ Takeda Pharmaceuticals International AG는 피고 Torrent Pharmaceuticals Limited/ Torrent Pharma, Inc.을(를) 상대로 특허 US9861630을(를) 침해하였다는 이유로 미국 델라웨어 지방법원에 소를 제기하였다.
분쟁경과 분쟁중
산업분류 화학∙바이오 > 의약품
계쟁제품 5 mg, 10 mg, 15 mg, and 20 mg dosage strengths of vortioxetine hydrobromide tablets, Generic version of TRINTELLIX� tablets
지재권번호/명칭 US9861630 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment
등록일 : 2018-05-15

목록

해당 콘텐츠/상담 담당자
담당부서 : 기반정보팀 | 담당자 : 박서경 주임 (02-2183-5827) 메일 보내기